Navigation Links
Zimmer Holdings to Present at Morgan Stanley 2012 Global Healthcare Conference
Date:8/17/2012

WARSAW, Ind., Aug. 17, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the Morgan Stanley 2012 Global Healthcare Conference at the Grand Hyatt in New York, New York, on September 11, 2012, at 8:00 a.m. Eastern Time.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
2. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
3. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
4. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2012 Results
5. Zimmer Holdings Names Christopher Begley to Board of Directors
6. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
7. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
8. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
9. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
10. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
11. China Kanghui Holdings Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):